Mesopral (Esomeprazole)

Esomeprazole irreversibly inhibits the gastric H⁺/K⁺‑ATPase (proton pump) in parietal cells, blocking the final step of acid secretion. This raises gastric pH, reduces irritation of the gastrointestinal lining, and creates an environment that supports healing and improves the activity of certain antibiotics.

The specific dose and dosing schedule of Mesopral are determined by the prescribing healthcare professional based on the patient’s condition, severity, and response to therapy. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Safety data for esomeprazole in pregnancy and lactation are limited. The prescriber will weigh potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare provider.

To place an order, submit an enquiry on the Mesopral product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mesopral (esomeprazole) is the S‑isomer of omeprazole and generally provides more consistent acid suppression with a slightly longer duration of action. Compared with other proton pump inhibitors, it may achieve higher intragastric pH levels, which can be advantageous in healing erosive disease, though clinical choice often depends on individual response and cost considerations.

Mesopral should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain stability and potency throughout its shelf life.

Mesopral is taken orally, usually as a whole tablet swallowed with water. It is typically taken before a meal, but patients should follow the specific timing instructions provided by their prescriber to achieve optimal acid control.

Serious adverse events, although rare, include severe allergic reactions (such as anaphylaxis), Clostridioides difficile‑associated colitis, significant hypomagnesemia that can lead to muscle cramps or cardiac arrhythmias, and long‑term bone fracture risk. Patients should seek immediate medical attention if they experience symptoms like rash, swelling, persistent diarrhea, or unexplained muscle weakness.

Mesopral is contraindicated in individuals with known hypersensitivity to esomeprazole or any component of the formulation. Caution is advised for patients with severe liver disease, those taking certain antiretrovirals that require an acidic environment, and patients with a history of C. difficile infection. The prescriber should evaluate each patient’s medical history before initiating therapy.